Solara Active Pharma Sciences Ltd Ordinary Shares SOLARA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹801.70
- Day Range
- ₹775.05–817.00
- 52-Week Range
- ₹263.59–830.00
- Bid/Ask
- ₹807.35 / ₹807.35
- Market Cap
- ₹38.76 Bil
- Volume/Avg
- 37,320 / 166,052
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.50
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,767
- Website
- https://www.solara.co.in
Comparables
Valuation
|
Metric
|
SOLARA
|
002020
|
MARKSANS
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 17.19 | 41.61 |
Price/Book Value | 3.36 | 1.79 | 6.71 |
Price/Sales | 2.50 | 2.40 | 6.12 |
Price/Cash Flow | — | 10.07 | 39.40 |
Price/Earnings
SOLARA
002020
MARKSANS
Financial Strength
|
Metric
|
SOLARA
|
002020
|
MARKSANS
|
|---|---|---|---|
Quick Ratio | 0.33 | 0.85 | 2.99 |
Current Ratio | 0.64 | 1.24 | 4.78 |
Interest Coverage | −3.53 | 85.45 | 33.90 |
Quick Ratio
SOLARA
002020
MARKSANS
Profitability
|
Metric
|
SOLARA
|
002020
|
MARKSANS
|
|---|---|---|---|
Return on Assets (Normalized) | — | 7.21% | — |
Return on Equity (Normalized) | — | 10.57% | — |
Return on Invested Capital (Normalized) | — | 8.90% | — |
Return on Assets
SOLARA
002020
MARKSANS
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Tpjshmlvf | Cgknw | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Vfhgstxkx | Qzsrtj | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Dqvnljn | Mvj | $48.4 Bil | |||
| Viatris Inc
VTRS
| Bkgwrzs | Cwsq | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Hhnymjwl | Khnz | $13.5 Bil | |||
| Catalent Inc
CTLT
| Ynqskckl | Jpvlb | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Gnwrbqqd | Pdtcrj | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Jnwrzjfj | Gtc | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Ghbtwxjrwj | Zrdhj | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Lrdqjvdp | Cqjk | $2.3 Bil |
United States